Market Signal Briefing

HomeStock IdeasLong IdeasEnergy Analysis

SummaryDenison Mines Corp. (DNN) is rated BUY (conditional on CNSC license approval), with a $4.18 price target and 8% discount rate.The Phoenix ISR project positions DNN in the lowest global cost quartile, leveraging innovative freeze wall technology and strong internal funding.Securing grid power and advancing multiple projects, DNN is well-placed to benefit from surging uranium demand driven by AI data center growth.Valuation sensitivity to uranium prices and binary licensing risk is high; CNSC approval could re-rate DNN to Tier-1 producer multiples.Editor's note: Seeking Alpha is proud to welcome Dev Shroff as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in DNN over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

I may purchase shares in the company myself within the next 24 hours, taking into account market trends.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Huntington Bancshares Incorporated (HBAN) Q4 2025 Earnings Call Transcript

Q4: 2026-01-21 Earnings SummaryEPS of $1.20 beats by $0.07

 |

Revenue of

$72.88M

(25.03% Y/Y)

misses by $767.20K

Equity Bancshares, Inc. (EQBK) Q4 2025 Earnings Call January 22, 2026 10:00 AM EST

Company Participants

Brian Katzfey - VP and Director of Corporate Development & Investor Relations
Brad Elliott - Founder, Chairman & CEO
Chris Navratil - Executive VP & CFO
Richard Sems - CEO & Director

Conference Call Participants

Ryan Payne - D.A. Davidson & Co., Research Division
Damon Del Monte - Keefe, Bruyette, & Woods, Inc., Research Division
Nathan Race - Piper Sandler & Co., Research Division
Anya Pelshaw
Brandon Rud - Stephens Inc., Research Division

Presentation

Operator

Hello, and welcome to the Equity Bancshares, Inc. 2025 Q4 Earnings Call. My name is Carla, and I will be coordinating your call today.

[Operator Instructions]

I would now like to hand you over to your host, Brian Katzfey, Vice President, Director of Corporate Development and Investor Relations, to begin. Please go ahead when you're ready.

Brian Katzfey
VP and Director of Corporate Development & Investor Relations

Good morning. Thank you for joining us today for Equity Bancshares' Fourth Quarter Earnings Call. Before we begin, let me remind you that today's call is being recorded and is available via webcast at investor.equitybank.com, along with our earnings release and presentation materials. Today's presentation contains forward-looking statements, which are subject to certain risks, uncertainties and other factors that could cause actual results to differ materially from those discussed. Following the presentation, we will allow time for questions and further discussion. Thank you all for joining us.

With that, I'd like to turn the call over to our Chairman and CEO, Brad Elliott.

Brad Elliott
Founder, Chairman & CEO

Good morning, everyone. Thanks for being here today. Joining me are Rick Sems, our bank CEO; and Chris Navratil, our CFO. I'm really proud to wrap up what's been a big year for Equity Bank. We ended 2025 with a strong balance sheet and earnings that

VANCOUVER, BC / ACCESS Newswire / January 22, 2026 / Usha Resources Ltd. ("Usha" or the "Company") (TSXV:USHA)(OTCQB:USHAF)(FSE:JO0) - on January 19, 2026, Totec Resources Ltd. ("Totec") completed its "Qualifying Transaction" (as such term is defined under TSX Venture Exchange Policy 2.4 - Capital Pool Companies) with Usha, 1540359 B.C. Ltd. ("Subco") and certain shareholders of Subco (the "Investors"), pursuant to which Usha and the Investors sold their respective interests in Subco to Totec (the "Transaction").

The Transaction was completed pursuant to a share purchase agreement dated October 22, 2025, as amended December 10, 2025, among Totec, Usha, Subco and the Investors. The purchase price paid by Totec for the Transaction was an aggregate of 35,500,000 common shares of Totec (the "Common Shares") issued to the shareholders of Subco (5,500,000 of which were issued to Usha and 30,000,000 of which were issued to the Investors) and $50,000 in cash paid to Usha.

Prior to the completion of the Transaction, Usha beneficially owned and controlled nil Common Shares. Upon completion of the Transaction, Usha beneficially owns and controls 5,500,000 Common Shares, representing 14.3% of the issued and outstanding Common Shares on a non-diluted basis.

Usha may acquire additional securities or dispose of existing securities on the basis of Usha's assessment of market conditions, reformulation of plans and/or other relevant factors, in each case in accordance with applicable securities regulatory requirements.

This disclosure is being made pursuant to National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issuers in connection with the filing of an early warning report regarding the Company's acquisition of securities of Totec. A copy of the Usha's early warning report will be available on Totec's profile on SEDAR+ at www.sedarplus.ca.

Contact:

Deepak Varshney
778-899-1780
[email protected]

SOURCE: Usha Resources Ltd.

Key Takeaways AMD expands AI reach via global deals with TCS, Oracle, Microsoft, and others for enterprise solutions. Helios rack-scale platform enables AMD to deliver exaflop-class performance for large-scale AI workloads.AMD expects over 80% AI revenue CAGR and over 60% data center growth, despite pressure from NVDA and AVGO. Advanced Micro Devices’ (AMD - Free Report) 2026 prospects are expected to benefit from an expanding enterprise footprint and rich partner base. The company has been inking deals with enterprises globally that include the likes of Tata Consultancy Services (TCS), HPE, Oracle, Google, Microsoft, Alibaba and IBM, among others.

AMD and TCS are collaborating to develop industry-specific AI and Generative AI (Gen AI) solutions. TCS will work with AMD to integrate Ryzen CPU-powered client solutions to deliver workplace transformation, while using EPYC CPUs, Instinct GPUs, and AI accelerators to modernize hybrid cloud and high-performance computing environments. The expanded collaboration with HPE is expected to boost the adoption of AMD's “Helios” rack-scale AI architecture.

AMD’s Helios rack-scale platform is suitable for handling yotta-scale AI infrastructure. A single Helios rack can deliver up to 3 AI exaflops and is optimized for massive, energy-efficient training of trillion-parameter models. Helios comprises Instinct MI455X accelerators, EPYC “Venice” CPUs and Pensando “Vulcano” NICs for scale-out networking and the open AMD ROCm software ecosystem. Oracle Cloud Infrastructure will launch the first publicly available AI supercluster using AMD’s Helios rack design. OpenAI has selected AMD as a preferred partner to build 6 gigawatts (GW) of next-generation AI computing capacity. The rollout will begin with 1 GW of AMD Instinct MI450 GPUs in the second half of 2026.

An expanding portfolio with the launch of the Instinct MI400 series lineup, Ryzen AI 400 and AI PRO 400 Series processors for AI PCs, along with a rich partner base, bodes well for the company’s data center business. AMD envisions the data center total addressable market to hit $1 trillion by 2030, suggesting a CAGR of more than 40% from roughly $200 billion estimated in 2025. AMD expects its data center AI revenues to see a CAGR of more than 80% over the next 3-5 years, driven by strong demand for instinct GPUs (MI450 Series and Helios rack-scale solutions) and expanding clientele that includes multiple hyperscalers, as well as sovereign opportunities. Overall data center business revenues and total revenues are expected to see a CAGR of more than 60% and greater than 35%, respectively, over the same time frame.

Tough Competition Hurts AMD’s Data Center ProspectsNVIDIA (NVDA - Free Report) and Broadcom (AVGO - Free Report) are major competitors in the Data Center space. NVIDIA is at the center of AI computing, with its products widely used across data centers, gaming and autonomous vehicles. The company’s newer Hopper 200 and Blackwell GPU platforms are being adopted quickly as customers work to grow their AI infrastructure.

Broadcom is benefiting from strong demand for its networking products and custom AI accelerators (XPUs). In fiscal 2025, AI revenues surged 65% to $20 billion from fiscal 2024. Broadcom’s current order backlog for AI switches exceeds $10 billion as AVGO’s latest 102-terabit per second Tomahawk 6 switch continues to gain traction. AVGO now expects first-quarter fiscal 2026 AI revenues to double year over year to $8.2 billion. AVGO’s expanding clientele, which now includes Anthropic, is a key catalyst.

AMD’s Share Price Performance, Valuation & EstimatesAMD shares have jumped 103.1% on a trailing 12-month basis, outperforming the broader Zacks Computer and Technology sector’s return of 19.1%.

AMD Stock’s Performance
Image Source: Zacks Investment Research

AMD stock is overvalued, with a forward 12-month price/sales of 9.18X compared with the broader sector’s 7.18X. AMD has a Value Score of F.

AMD Valuation
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for first-quarter 2026 earnings is pegged at $1.20 per share, up by a penny over the past 30 days, suggesting 25% year-over-year growth.
 

AMD currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways ALLY posted Q4 adjusted EPS of $1.09, beating estimates, with GAAP net income rising to $300 million.Ally Financial benefited from higher net finance revenue, lower provisions and expenses, and a 3.51% NIM.ALLY saw loans and deposits rise sequentially as non-performing loans and charge-offs declined. Ally Financial’s (ALLY - Free Report)  fourth-quarter 2025 adjusted earnings of $1.09 per share surpassed the Zacks Consensus Estimate of $1.01. The bottom line reflected a 39.7% jump from the year-ago quarter.

Results primarily benefited from a rise in net finance revenues and other revenues. Also, lower provisions and a decline in expenses were tailwinds. An increase in loan balances further supported the results to some extent.

After considering non-recurring items, net income attributable to common shareholders (GAAP basis) was $300 million compared with $81 million in the prior-year quarter.

Adjusted earnings of $3.81 per share for 2025 surpassed the Zacks Consensus Estimate of $3.74. The bottom line increased 62.1% from the previous year. Net income attributable to common shareholders (GAAP basis) was $742 million compared with $558 million in 2024.

Ally Financial’s Revenues Improve, Expenses DeclineTotal quarterly GAAP net revenues were $2.12 billion, up 4.8% from the prior-year quarter. However, the top line marginally missed the Zacks Consensus Estimate of $2.13 billion. Adjusted total revenues were $2.17 billion, up 3.7% from the prior-year quarter.

Total GAAP net revenues in 2025 were $7.91 billion, down 3.3% from the previous year. The top line marginally missed the Zacks Consensus Estimate of $7.92 billion.

Quarterly net financing revenues grew 5.9% from the prior-year quarter to $1.60 billion. The rise was primarily driven by lower interest expenses. The adjusted net interest margin was 3.51%, up 18 basis points.

Total other revenues were $525 million, up 1.5% year over year. The rise was primarily driven by a rise in net other gain on investments.

Total non-interest expenses declined 8.1% year over year to $1.25 billion.

The adjusted efficiency ratio was 50.8%, down from 52.8% in the year-ago period. A fall in the efficiency ratio indicates an improvement in profitability.

ALLY’s Loans & Deposit Balances RiseAs of Dec. 31, 2025, total net finance receivables and loans amounted to $134 billion, up 2.2% from the prior-quarter end.

Deposits also increased 2.2% on a sequential basis to $151.6 billion.

Ally Financial’s Credit Quality ImprovesNon-performing loans were $1.37 billion as of Dec. 31, 2025, down 8.1% year over year. In the reported quarter, Ally Financial recorded net charge-offs of $452 million, down 16.8% from the prior-year quarter.

Further, provision for loan losses was $487 million, down 12.6% year over year. The decline was led by continued retail auto net charge-off improvement and the sale of Credit Card.

Capital Ratios of ALLY ImproveAs of Dec. 31, 2025, the total capital ratio was 13.6%, up from 13.2% in the prior-year period. The tier 1 capital ratio was 11.7%, up from 11.3% as of Dec. 31, 2024.

Also, the common equity tier 1 (CET1) capital ratio increased to 10.2% from 9.8% in the prior-year period.

Our View on Ally FinancialALLY’s business-restructuring initiatives, balance sheet repositioning efforts and rising demand for consumer loans will likely strengthen its financials. However, weak credit quality amid a tough operating backdrop remains a key near-term headwind.

Currently, Ally Financial carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Performance of Finance StocksThe PNC Financial Services Group, Inc.’s (PNC - Free Report) fourth-quarter 2025 earnings per share of $4.88 surpassed the Zacks Consensus Estimate of $4.23. In the prior-year quarter, the company reported EPS of $3.77.

PNC’s results were aided by record revenue growth, driven by a rise in net interest income and fee income. Rising loan and deposit balances, along with a decline in provisions for credit losses, were other positives. However, an increase in expenses acted as a spoilsport.

KeyCorp’s (KEY - Free Report) fourth-quarter 2025 adjusted earnings per share from continuing operations of 41 cents outpaced the Zacks Consensus Estimate of 38 cents. The bottom line reflected a 7.9% rise from the prior-year quarter.

KEY’s results primarily benefited from higher net interest income and non-interest income. The rise in average loans and deposit balances was another positive. However, higher expenses and a jump in provisions were the undermining factors.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming March 16, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Smart Digital Group Limited (“SDM” or the “Company”) (NASDAQ: SDM) securities between May 5, 2025 and September 26, 2025, inclusive (the “Class Period”).

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SMART DIGITAL GROUP LIMITED (SDM), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On September 26, 2025, NASDAQ temporarily halted trading of SDM stock due to volatility after the Company’s stock activity spiked with over 270,000 orders at 9:33 AM alone—approximately 30% of the Company’s average daily volume in a single minute. Trading resumed a little over an hour later with SDM’s stock price plummeting, closing at $1.85 per share, 88% less than the prior day’s closing price.

After market hours, the United States Securities and Exchange Commission ("SEC") disclosed a temporary suspension of trading in SDM ordered for September 29, 2025 through October 25, 2025 due to “potential manipulation in the securities of SDM effectuated through recommendations made to investors by unknown persons via social media to purchase the securities of SDM, which appear to be designed to artificially inflate the price and volume of the securities of SDM.”

On October 11, 2025, NASDAQ announced that trading in SDM would remain suspending pending receipt of “additional information requested from the company.” Trading of SDM’s stock continues to remain suspended.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) SDM was the subject of a market manipulation and fraudulent promotion scheme involving social-media based misinformation and impersonators posing as financial professionals; (2) insiders and/or affiliates used and/or intended to use offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; (3) SDM's public statements and risk disclosures omitted any mention of realized risk of fraudulent trading or market manipulation used to drive the Company's stock price; (4) as a result, SDM securities were at unique risk of a sustained suspension in trading by either or both of the SEC and NASDAQ; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired SDM securities during the Class Period, you may move the Court no later than March 16, 2026 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements.

Contact Us To Participate or Learn More:

If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: [email protected],
Visit our website at: www.howardsmithlaw.com.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

More News From Law Offices of Howard G. Smith

Key Takeaways RGTI and QBTS shares gained more than 40% in six months, reflecting growing investor interest.RGTI focuses on gate-based, chiplet superconducting systems aimed at long-term fault tolerance.QBTS targets near-term revenue with annealing systems delivered through its Leap cloud platform. Quantum computing continues to capture investor attention as one of the most ambitious frontier technologies in the market today. While the industry is still early and timelines remain uncertain, tangible progress is being made as companies move beyond theory toward practical applications. Use cases in optimization, logistics, materials science, and complex decision-making are gradually taking shape, giving investors a clearer sense of how quantum systems could eventually deliver real economic value. For those with a long-term mindset and a tolerance for volatility, quantum computing offers exposure to a technology that could fundamentally reshape computing over the next decade and beyond.

Within this evolving landscape, Rigetti Computing (RGTI - Free Report) and D-Wave Quantum (QBTS - Free Report) represent two very different approaches to building a quantum business. Rigetti is focused on gate-based, superconducting quantum processors, betting that steady improvements in chip design, fidelity, and system architecture will position it well for fault-tolerant quantum computing over time. D-Wave, on the other hand, is pursuing a more commercially oriented path through quantum annealing, emphasizing near-term customer adoption, recurring revenue, and practical problem-solving today. In this faceoff, we examine how the companies are executing on their strategy, where their strengths and limitations lie, and which stock may offer the more compelling risk-reward profile for investors right now.

Price Performance of RGTI & QBTSShares of Rigetti have soared 47.2%, while QBTS stock has gained of 41.6% in the last six-month period.

Image Source: Zacks Investment Research

Architecture & Technology StrategyAt a technology level, Rigetti and D-Wave Quantum are not just competitors; they are pursuing fundamentally different visions of what useful quantum computing looks like. Rigetti is firmly committed to gate-based quantum systems built on superconducting qubits; a path widely viewed as essential for achieving fault-tolerant, general-purpose quantum computing over the long term. Over the past year, Rigetti has sharpened this strategy by shifting toward a chiplet-based architecture, breaking large processors into smaller, modular units that can be manufactured, tested, and scaled more efficiently. This approach is designed to improve yields, reduce noise, and create a more repeatable hardware roadmap, rather than relying on increasingly complex monolithic chips.

D-Wave Quantum, by contrast, is focused on solving real-world problems today rather than building toward a distant, universal quantum future. Its quantum annealing systems are purpose-built for optimization workloads such as scheduling, logistics, and resource allocation, areas where customers can already experiment with production-level use cases. While annealing is not a universal quantum computing model, D-Wave has leaned into its strengths by steadily increasing qubit counts, improving system reliability and expanding access through cloud-based services. This has allowed the company to generate recurring revenue and build a commercial narrative that resonates with enterprise and government users.

Business Model & Go-to-Market StrategyRigetti’s commercial model still reflects its roots as a hardware-first, R&D-heavy quantum company. The company generates most of its revenues from government contracts, research institutions and early-stage enterprise collaborations, many of which are tied to specific development milestones rather than ongoing usage. These relationships are strategically important; they validate Rigetti’s technology and help fund continued hardware innovation, but they also result in lumpy, less predictable revenue. Rigetti does offer access to its systems via cloud platforms, yet customer usage remains modest and largely experimental. For investors, Rigetti’s go-to-market strategy is still about proving technical viability and refining its architecture, with commercialization clearly a secondary priority for now.

D-Wave Quantum’s approach looks very different and far more commercially oriented. D-Wave Quantum has built its business around delivering quantum computing as a service, with customers accessing its annealing systems through the Leap cloud platform. This model emphasizes recurring revenue driven by usage, subscriptions and long-term customer relationships rather than one-off research engagements. Importantly, D-Wave Quantum has already signed multiple enterprise and public-sector customers using its systems for optimization problems in areas like logistics, manufacturing, and scheduling. While revenue levels are still small and profitability remains a long-term goal, D-Wave’s go-to-market strategy offers clearer visibility into adoption trends and a more traditional SaaS-like trajectory that investors can track quarter to quarter.

Who Is Better Positioned for Quantum Advantage?Rigetti and D-Wave Quantum are pursuing quantum advantage on very different timelines. Rigetti is focused on building scalable, fault-tolerant gate-based systems, with its chiplet-based superconducting architecture aimed at solving long-term challenges around error rates and hardware scalability. By controlling much of the technology stack end to end, Rigetti is positioning itself for a future where large, general-purpose quantum machines can deliver transformational value, though that future remains several years away and enterprise adoption is still limited.

D-Wave Quantum, meanwhile, defines quantum advantage more pragmatically. Its annealing-based systems are designed to solve specific optimization problems today, allowing customers to experiment with real-world applications without waiting for fully fault-tolerant machines. This narrower but more immediate focus has enabled D-Wave Quantum to demonstrate earlier signs of practical value and build commercial traction, even if its technology is not intended to address the full range of quantum workloads.

Ultimately, the choice comes down to time horizon and risk appetite. Rigetti represents a longer-term, higher-risk bet on where quantum computing is headed, while D-Wave Quantum offers a clearer path to near-term relevance by showing where quantum computing can already make a difference.

How Do Estimates Compare for RGTI & QBTS?The Zacks Consensus Estimate for RGTI’s 2026 sales implies year-over-year growth of 197.6%. For 2026, the loss per share is projected to be 18 cents compared with 68 cents a year ago.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for QBTS 2026 sales implies year-over-year growth of 61.1%. For 2026, the loss per share is projected to be 19 cents compared with 20 cents a year ago.

Image Source: Zacks Investment Research

RGTI or QBTS: Which Is a Better Pick?From a ranking standpoint, Rigetti and D-Wave Quantum look evenly matched on the surface. Each stock presently carries a Zacks Rank #3 (Hold) and a Value Score of F, underscoring a familiar reality for quantum investors. These names are priced on future potential rather than near-term fundamentals. As a result, neither stock stands out as a value play today, and expectations remain elevated across the space. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Where the divergence becomes clearer is in growth and momentum profiles. Rigetti holds a Growth Score of C, reflecting relatively more grounded expectations tied to its incremental progress in gate-based hardware and architecture development. However, its Momentum Score of F suggests limited near-term market enthusiasm. D-Wave, on the other hand, carries a weaker Growth Score of F, indicating uncertainty around longer-term expansion. Still, its Momentum Score of B highlights stronger recent investor interest, likely driven by its clearer commercialization narrative and recurring revenue model.

For investors weighing the two, the choice again comes down to time horizon and style. D-Wave may appeal more to those looking for near-term momentum and evidence of commercial traction, even if long-term growth visibility remains uneven. Rigetti, by contrast, appears better suited for investors willing to be patient, favoring a more measured growth profile tied to long-term technological execution rather than short-term excitement.

Key Takeaways ADBE's Digital Media revenues rose 11% to $17.65B in FY25, making up 74% of total revenues.MAUs for Acrobat, Creative Cloud, Express and Firefly rose over 15% year over year in FY25. ADBE expects 10.2% ARR growth in FY26, driven by AI features and broader enterprise adoption. Adobe’s (ADBE - Free Report) Digital Media segment continues to anchor the company’s growth trajectory. In fiscal 2025, Digital Media revenues reached $17.65 billion, up 11% year over year on a reported and a constant currency basis. The segment accounted for 74% of revenues in the fiscal year, while annualized recurring revenue (ARR) totaled $19.20 billion, up 11.5% year over year.

Growth has been driven by the continued adoption of its cloud-based platform, Acrobat and Express, supported by the integration of AI-powered capabilities such as Firefly and Acrobat AI Assistant. These tools are enabling faster content creation and document productivity, directly influencing subscription renewals and premium upgrades. In fiscal 2025, Acrobat, Creative Cloud, Express and Firefly achieved total MAU growth of greater than 15% year over year. Adobe now targets ARR growth of 10.2% for fiscal 2026, driven by an innovative AI-powered portfolio, the expanding adoption of enterprises and a large market opportunity.

Adobe is infusing AI innovations into Acrobat, including new AI chat experiences to PDFs with simple, natural-language prompts. The company is combining Acrobat and Express to transform productivity and creativity together, making it fast and easy to generate presentations and podcasts from documents in minutes with AI. The new features are available in Acrobat Studio, which includes advanced PDF tools, AI Assistant and PDF Spaces from Acrobat and Express Premium capabilities in one AI-powered home for productivity.

Acrobat users are increasingly relying on Acrobat AI Assistant to consume content at a faster rate and are using Express to create richer PDFs, customized presentations and animated designs. ADBE is seeing increasing adoption of Express capabilities within Acrobat, driven by growing demand for creative functionality. Adobe is gaining traction among individuals, small and medium businesses and enterprises, thanks to Acrobat AI Assistant, as well as Express premium plans. This is expected to drive top-line growth in fiscal 2026.

Adobe Faces Tough Competition in the AI DomainADBE’s AI business is minuscule compared with Microsoft (MSFT - Free Report) and Alphabet (GOOGL - Free Report) . Microsoft’s Intelligent Cloud revenues are benefiting from growth in Azure AI services and a rise in the AI Copilot business. The company's substantial investment in OpenAI provides exclusive access to leading-edge language models, creating a significant competitive moat in enterprise AI adoption. Microsoft monetizes AI through existing customer relationships, reducing customer acquisition costs while expanding revenue per user.

Alphabet’s focus on leveraging AI to drive growth is a key catalyst. AI is infused heavily across its offerings, including Search and Google Cloud. AI Overviews and AI Mode are driving overall queries and commercial queries, thereby driving monetization opportunities. The addition of shopping capabilities in AI Mode is now helping people shop conversationally in Search. Google has added new AI features in Search that help users build travel plans.

ADBE’s Share Price Performance, Valuation & EstimatesAdobe shares have lost 32.6% in a year, underperforming the broader Zacks Computer and Technology sector’s return of 19%.

Adobe Stock Lags Sector in a Year
Image Source: Zacks Investment Research

ADBE stock is trading at a discount, as suggested by a Value Score of B.

In terms of forward price/sales, Adobe shares are trading at a higher multiple of 4.58 compared with the broader sector’s 7.18.

ADBE Stock is Cheap
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for first-quarter fiscal 2026 earnings is pegged at $5.88 per share, up a couple of cents over the past 30 days, suggesting 15.8% growth from the figure reported in the year-ago quarter. 
 

Adobe currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that it adjourned its annual and special meeting of shareholders (the “Meeting”) until February 12, 2026.

The Meeting will now be held on February 12, 2026, at 9:00 a.m. New York Time/4:00 p.m. Cape Town time at Venture Workspace Riverlands, Office Building 4, Riverlands, 51 Gogosoa Street, Observatory, Cape Town, 7935, South Africa.

The adjournment is a result of the requisite quorum of shareholders not having been achieved to hold the Meeting. The Company is working with its proxy agents to help ensure that quorum is obtained for the reconvened meeting on February 12, 2026. For details concerning the business of the Meeting, please see the Company’s notice of meeting and management information circular dated January 2, 2026, filed on EDGAR. Please note that the record date for the Meeting, close of business on December 23, 2025, has not changed.

About Psyence BioMed

Psyence Biomedical Ltd. (Nasdaq: PBM) is one of the few multi-asset, vertically integrated biopharmaceutical companies specializing in psychedelic-based therapeutics. It is the first life sciences biotechnology company focused on developing nature-derived (non-synthetic) psilocybin and ibogaine-based psychedelic medicine to be listed on Nasdaq. We are dedicated to addressing unmet mental health needs. We are committed to an evidence-based approach in developing safe, effective, and FDA-approved nature-derived psychedelic treatments for a broad range of mental health disorders.

Contact Information for Psyence Biomedical Ltd.
Email: [email protected]
Media Inquiries: [email protected]
General Information: [email protected]

Investor Contact:
Michael Kydd
Investor Relations Advisor
[email protected]

Forward Looking Statements

This communication contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations, and intentions with respect to future operations, products and services; and other statements identified by words such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “believe,” “intend,” “plan,” “projection,” “outlook” or words of similar meaning.

Forward-looking statements in this communication include statements regarding the reconvening of the Meeting and the timing (if any) of the Meeting. These statements are based on current assumptions and expectations, including that the Company will succeed in obtaining quorum for the reconvened Meeting. These assumptions may prove incorrect. There can be no assurance that the Company will be able to obtain quorum at the reconvened Meeting. There are numerous risks and uncertainties that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.

These risks and uncertainties include, among other difficulties, delays or challenges in obtaining quorum for the Meeting, including the possibility of claims or proceedings challenging the validity of quorum for the Meeting or the Meeting itself. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s final prospectus (File No. 333-298285) filed with the Securities and Exchange Commission (the “SEC”) on November 3, 2025 and other documents filed by Psyence BioMed from time to time with the SEC.

These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Actual results and future events could differ materially from those anticipated in such statements. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except as required by law, Psyence BioMed does not intend to update these forward-looking statements.

The Company does not make any medical, treatment or health benefit claims about its proposed products. The U.S. Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding psilocybin, psilocybin analogues, or other psychedelic compounds or nutraceutical products. The efficacy of such products has not been confirmed by authorized clinical research. There is no assurance that the use of psilocybin, psilocybin analogues, or other psychedelic compounds or nutraceuticals can diagnose, treat, cure or prevent any disease or condition. Vigorous scientific research and clinical trials are needed. The Company’s product candidates are investigational and have not been approved by any regulatory authority for use in the treatment of any disease or condition, and clinical results (if any) may not be indicative of future results. Any references to quality, consistency, efficacy, and safety of potential products do not imply that the Company has verified such in clinical trials or that the Company will complete such trials. If the Company cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on the Company’s performance and operations.

Atlantic Union Bankshares Corporation (AUB) Q4 2025 Earnings Call January 22, 2026 9:00 AM EST

Company Participants

William Cimino - Senior VP & Director of Investor Relations
John Asbury - President, CEO & Director
Robert Gorman - Executive VP & CFO
David Ring - Executive Vice President
Shawn O’Brien - Executive Vice President

Conference Call Participants

Sun Young Lee - TD Cowen, Research Division
David Bishop - Hovde Group, LLC, Research Division
Stephen Moss - Raymond James & Associates, Inc., Research Division
Brian Wilczynski - Morgan Stanley, Research Division
Hannah Wynn
Stephen Scouten - Piper Sandler & Co., Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to Atlantic Union Bankshares Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that today's conference is being recorded. I will now hand the conference over to your speaker host, Bill Cimino, Senior Vice President of Investor Relations. Please go ahead.

William Cimino
Senior VP & Director of Investor Relations

Thank you, [ Olivia, ] and good morning, everyone. I have Atlantic Union Bankshares' President and CEO, John Asbury; and Executive Vice President and CFO, Rob Gorman with me today. We also have other members of our executive management team with us for the question-and-answer period. Please note that today's earnings release and the accompanying slide presentation we are going through on this webcast are available to download on our investor website, investors.atlanticunionbank.com.

During today's call, we will comment on our financial performance using both GAAP metrics and non-GAAP financial measures. Important information about these non-GAAP financial members -- measures, including reconciliations to comparable GAAP measures, is included in the appendix to our slide presentation and in our earnings release for the fourth quarter and full year 2025.

We'll also make forward-looking statements, which are not statements of historical fact and are subject to risks and

STURGIS, MI / ACCESS Newswire / January 22, 2026 / Sturgis Bancorp, Inc. (OTCQX:STBI) today announced that its Board of Directors has declared a cash dividend of $0.18 per common share, payable March 13, 2026, to stockholders of record at the close of business on February 13, 2026. This declaration increases the quarterly dividend by $0.01 to the highest level in the Company's history.

About Sturgis Bancorp, Inc.

Sturgis Bancorp, Inc. is the holding company for Sturgis Bank & Trust Company (the Bank), and its subsidiaries: Oakleaf Financial Services, Oak Mortgage, Ayres/Oak Insurance, and Oak Title Services. The Bank provides a full array of trust, commercial, and consumer banking services from banking centers in: Sturgis, Bangor, Bronson, Centreville, Climax, Colon, Marshall, Niles, Portage, South Haven, St. Joseph, Three Rivers, and White Pigeon, Michigan. Oakleaf Financial Services offers a complete range of investment and financial-advisory services. Oakleaf Mortgage offers residential mortgages in all markets of the Bank. Ayres/Oak Insurance offers various competitive commercial and consumer insurance products. Oak Title Services offers commercial and consumer title insurance services.

For additional information and updates, visit our website at www.sturgis.bank.

Sturgis Bancorp, Inc. Contacts

Jason J. Hyska, President & CEO, or Brian P. Hoggatt, CFO - (269) 651-9345

SOURCE: Sturgis Bancorp, Inc.

Key Takeaways Celestica plans Q4 results on Jan. 28, with CCS revenue expected to rise to $2.66B from $1.73B a year ago.CLS launched SD6300 storage and DS6000/DS6001 switches, doubling capacity for AI/ML data center workloads.CLS sees strong hyperscaler demand for 800G switches, offsetting some weakness in the enterprise market. Celestica, Inc. (CLS - Free Report) is scheduled to report fourth-quarter 2025 earnings on Jan. 28. In the to-be-reported quarter, the company is likely to have recorded higher revenues from the Connectivity & Cloud Solutions segment owing to healthy demand in the communications end market.

Factors at Play?During the quarter, Celestica introduced a leading-edge storage platform, the SD6300 ultra-dense storage expansion system, to cater to the exponential AI data growth across traditional enterprise and hyperscale data centers. With a compact footprint of only 1125 mm (including cable management assembly), the SD6300 maximizes utilization of existing data center floor space as it can be accommodated within standard 1200 mm racks.

In the to be reported quarter, Celestica introduced two new 1.6TbE data center switches, the DS6000 and DS6001, to support high-bandwidth, AI/ML data center applications. While the DS6000 is a 3RU, 64-port x 1.6TbE data center switch for traditional air-cooled data center installations, the DS6001 is a 2OU, 64-port x 1.6TbE switch offering a hybrid cooled solution based on the 21-inch OCP ORv3 rack. Together, the switches double the switching capacity of Celestica’s current offerings. Such innovative product launches are expected to have a favorable impact on fourth-quarter results.

Celestica has gained solid market traction in the fast-growing AI data center market. Strong demand for its 800G switches among hyperscalers is expected to drive growth in the communications end market. Despite some weakness in the Enterprise end market, healthy traction in the AI/ML compute business will likely drive growth.

Overall ExpectationsThe Zacks Consensus Estimate for CCS revenues is pegged at $2.66 billion, indicating a growth from $1.73 billion a year ago. Net income is projected at $218.5 million.

The Zacks Consensus Estimate for total revenue is pegged at $3.45 billion, indicating 35.46% year over year growth. The consensus mark for earnings is currently pegged at $1.73 per share, indicating growth from $1.11 in the year-earlier quarter.

Earnings WhispersOur proven model does not conclusively predict an earnings beat for Celestica for the fourth quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the chances of an earnings beat. That is not the case here.

You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Celestica currently has an ESP of 0.00% with a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.

Stocks to ConsiderHere are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:

Corning Incorporated (GLW - Free Report) is set to release quarterly numbers on Jan 28. It has an Earnings ESP of +1.72% and sports a Zacks Rank #2.

The Earnings ESP for Amphenol Corporation (APH - Free Report) is +3.78% and it carries a Zacks Rank of 2. The company is scheduled to report quarterly numbers on Jan 28.

The Earnings ESP for SAP (SAP - Free Report) is +0.57% and it carries a Zacks Rank of 2. The company is scheduled to report quarterly numbers on Jan 29.

Key Takeaways Enterprise Products' midstream network generates fee-based revenue, largely insulated from oil price swings.EPD operates more than 50,000 miles of pipelines booked for the long term, supporting predictable cash flows.KMI and ENB also rely on fee-based midstream assets, with sizable project backlogs securing cash flows. The price of West Texas Intermediate is currently hovering around the $60-per-barrel mark. In its latest short-term energy outlook, the U.S. Energy Information Administration (EIA) projected the spot average West Texas Intermediate price at $52.21 per barrel for 2026 and $50.36 per barrel for the next year. Thus, EIA’s projection for low oil prices, due to rising inventories, could hurt the businesses of many energy companies. But, unlike most energy players, Enterprise Products Partners LP’s (EPD - Free Report) business is not highly vulnerable to the fluctuations in commodity prices.

This is because Enterprise Products Partners is a leading midstream player, and therefore, it has a resilient business model. EPD has a pipeline network that spans more than 50,000 miles, transporting oil, natural gas, refined products and other commodities. Thus, the partnership generates stable fee-based revenues from the midstream assets, irrespective of the volatility in commodity prices, as the assets are booked by shippers for a long term.

Due to the resilience of its business model, the partnership has been able to return capital to unitholders on an ongoing basis. Since its IPO, Enterprise Products has returned billions to unitholders through repurchases and distributions.

KMI & ENB Also Have Stable Business ModelsKinder Morgan Inc. (KMI - Free Report) and Enbridge Inc. (ENB - Free Report) are two other midstream energy majors. By the very nature of their businesses, both KMI and ENB also have predictable cash flows. This is because KMI and ENB generate stable fee-based earnings from their respective midstream assets.

As of the September-end quarter of 2025, KMI’s project backlog was $9.3 billion. ENB, in contrast, mentioned that it has secured a capital program of billions of Canadian dollars. Thus, both Kinder Morgan and Enbridge have secured additional cash flows.

EPD’s Price Performance, Valuation & EstimatesUnits of Enterprise Products have jumped 4.5% over the past year against the 7.7% decline of the composite stocks belonging to the industry.

From a valuation standpoint, EPD trades at a trailing 12-month enterprise value to EBITDA (EV/EBITDA) of 10.69X. This is below the broader industry average of 10.82X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for EPD’s 2026 earnings has seen upward estimate revisions over the past seven days.

Image Source: Zacks Investment Research

Enterprise Products currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

President Trump has followed through on his threat to sue JPMorgan Chase and CEO Jamie Dimon for $5 billion, accusing the nation’s largest bank of politically motivated “debanking” after Jan. 6.

The suit, filed Thursday in Florida state court in Miami, claims JPMorgan severed Trump’s banking ties in early 2021 for political reasons, abruptly closing multiple accounts tied to the president and his businesses after decades-long relationship.

Trump’s attorney, Alejandro Brito, alleges the bank acted “without warning or remedy,” giving Trump and his affiliated entities just weeks to move hundreds of millions of dollars and providing no recourse, a decision the lawsuit says violated JPMorgan’s own code of conduct and amounted to unfair and deceptive trade practices.

President Trump has followed through on his threat to sue JPMorgan Chase and CEO Jamie Dimon for $5 billion. AP “We set high expectations and hold ourselves accountable. We do the right thing — not necessarily the easy or expedient thing. We abide by the letter and spirit of the laws and regulations everywhere we do business and have zero tolerance for unethical behavior,” the lawsuit states, citing the bank’s code of conduct.

“Despite claiming to hold these principles dear, JPMC violated them by unilaterally — and without warning or remedy — terminating several of Plaintiff’s bank accounts,” the lawsuit claims.

The filing alleges that JPMorgan’s decision was driven by what it calls “political and social motivations,” accusing the bank of seeking to distance itself from Trump and his conservative views in the aftermath of the Jan. 6, 2021 Capitol riot.

The lawsuit further claims JPMorgan placed Trump, his family and affiliated businesses on an internal “blacklist” shared with other federally regulated banks, an allegation the filing says led other financial institutions to refuse to do business with him and caused significant financial and reputational harm.

“Given that Plaintiffs have always complied with all applicable banking rules and regulations and their wealth management accounts were in good standing, JPMC’s publication of President Trump, the other Plaintiffs, the Trump Organization and its affiliated entities, and/or the Trump family’s names on this blacklist, is an intentional and malicious falsehood,” the lawsuit states.

Trump alleges that JPMorgan, headed by Dimon (pictured), closed his accounts for political reasons. AP Trump is alleging that JPMorgan Chase engaged in “an unfair and deceptive trade practice” by directing the publication of the names to the list, noting that the bank “had no legitimate basis to do so and knew that doing so would induce, and did in fact induce, other banking institutions not to deal with them.”

A JPMorgan spokesperson told The Post: “JPMC does not close accounts for political or religious reasons. We do close accounts because they create legal or regulatory risk for the company.”

“We regret having to do so but often rules and regulatory expectations lead us to do so,” the spokesperson added.

JPMorgan closed Trump’s accounts following the Jan. 6, 2021, riots at the US Capitol. AFP via Getty Images “We have been asking both this Administration and prior administrations to change the rules and regulations that put us in this position, and we support the Administration’s efforts to prevent the weaponization of the banking sector.”

Trump’s relationship with JPMorgan has deteriorated sharply amid overlapping political, regulatory and personal disputes.

The lawsuit follows months of friction, including Dimon’s public criticism of some Trump administration’s policies — most notably his warning that the Justice Department’s criminal probe into Federal Reserve Chair Jerome Powell risks undermining the central bank’s independence and could backfire by pushing interest rates higher.

Start your day with all you need to know Morning Report delivers the latest news, videos, photos and more.

Thanks for signing up!

JPMorgan has also pushed back against a White House proposal to cap credit card interest rates at 10% for a year, with bank executives warning the move could restrict access to credit, hurt consumers and disrupt the financial system.

Tensions spilled into the open again after Dimon criticized Trump’s immigration crackdown at the World Economic Forum in Davos, calling for calmer rhetoric and questioning aggressive ICE enforcement tactics — remarks that marked one of the most direct rebukes of the president by a sitting Wall Street CEO.

Trump has not been shy about wielding the threat of litigation against his perceived adversaries.

The president has reached settlements with Paramount, Disney’s ABC News, YouTube and Meta, stemming from disputes over interviews, on-air statements and the suspension of Trump’s social media accounts after Jan. 6.

Those cases were resolved without admissions of wrongdoing, as companies opted to pay tens of millions of dollars rather than face prolonged courtroom battles.

The Post has sought comment from the White House.

Philadelphia, Pennsylvania--(Newsfile Corp. - January 22, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Varonis Systems, Inc. (NASDAQ: VRNS) ("Varonis" or the "Company") on behalf of investors who purchased or otherwise acquired Varonis securities during the period of February 4, 2025 through October 28, 2025 (the "Class Period").

Investor Deadline: Investors who purchased Varonis securities during the Class Period may, no later than March 9, 2026, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.

Headquartered in Miami, Fla., Varonis is a global security company offering software products to detect advanced security threats using AI-powered technologies.

According to the suit, investors learned the previously-concealed truth as to the Company's customer renewals and conversions on October 28, 2025, when Varonis announced its third quarter 2025 financial results. On that date, the Company disclosed a significant annual recurring revenue (ARR) miss and reduced its guidance for the full fiscal year 2025 - despite having raised its projections in the previous two consecutive quarters. The Company blamed weaker than expected renewals and conversions in their federal and non-federal on-premises subscription business. In addition, Varonis announced at the same time the end-of-life of its self-hosted solution, as well as a 5% headcount reduction.

Following this news, Varonis' common stock declined dramatically, from a closing price of $63.00 per share on October 28, 2025 to a close of $32.34 per share on October 29, 2025 - a decline of $30.66 per share, or more than 48%, in a single day.

If you are a Varonis investor and would like to learn more about this action, CLICK HERE or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [email protected] or (267)764-4865.

About Berger Montague
Berger Montague is one of the nation's preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/281279

Source: Berger Montague

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

The video game publisher behind the Assassin’s Creed series has cancelled six projects including a remake of Prince of Persia: The Sands of Time as it fights to stay competitive in the global gaming market.

Ubisoft announced a sweeping reorganisation and said it would cancel six games, sending its shares to their lowest level in more than a decade on Thursday.

Ubisoft is abandoning development of six titles, including a highly anticipated remake of Prince of Persia- a series that dates back to 1989 and received an ill-fated Hollywood adaptation in 2010 – while a further seven would be delayed. Studios in Halifax, Canada and Stockholm are being closed, with restructurings to follow in other countries, it said.

After the announcement, Ubisoft’s shares fell by a third to their lowest level since 2011 on Thursday, valuing the company at €590m (£514m) compared with a peak of more than €10bn in the previous decade. The Paris-based company said it planned to split its operations into five creative divisions organised by genre, part of a broader attempt to sharpen focus and rein in costs after years of disappointing releases and weak results.

The company said the restructuring was driven by the competitive market for AAA games, the term for big-budget, high-profile titles like Grand Theft Auto.

“The triple-A industry has become persistently more selective and competitive with rising development costs and greater challenges in creating brands,” said Ubisoft’s founder and chief executive, Yves Guillemot.

However, Guillemot added that successful triple-A games have “more financial potential than ever”.

Ubisoft also blamed an “increasingly competitive market” for shooters, a key genre for the industry.

Laurent Michaud, a gaming industry economist, said action adventure titles like Prince of Persia were out of step with a market dominated currently by shooters like Fortnite and Call of Duty, cooperative adventure titles such as Peak, sports titles and multiplayer games such as those available on the Roblox platform.

“The expectations of gamers are quite different to where they were 10 years ago. That’s why it’s difficult to keep in touch with an audience that has changed so much over the years.”

He added: “Ubisoft is still one of the most popular content providers in the video games industry. It has developed one of the best IP slates in the industry but even if the games are really good, it is not enough. It has to meet people’s expectations and tastes.”

The latest overhaul follows several difficult years marked by game delays, cancellations and weak execution, which have eroded investor confidence and strained the group’s finances. In November 2025, Ubisoft postponed the publication of its half-year results at the last minute, triggering a week-long suspension of trading in its shares and bonds. The company later said an accounting change had revealed a breach of the terms for its debt.

Investors interested in Food - Miscellaneous stocks are likely familiar with Kerry Group PLC (KRYAY) and McCormick (MKC). But which of these two stocks presents investors with the better value opportunity right now?

Investors interested in stocks from the Mining - Miscellaneous sector have probably already heard of Norsk Hydro ASA (NHYDY - Free Report) and Anglo American (NGLOY - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.

Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.

Norsk Hydro ASA has a Zacks Rank of #1 (Strong Buy), while Anglo American has a Zacks Rank of #2 (Buy) right now. Investors should feel comfortable knowing that NHYDY likely has seen a stronger improvement to its earnings outlook than NGLOY has recently. But this is just one factor that value investors are interested in.

Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.

Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.

NHYDY currently has a forward P/E ratio of 9.08, while NGLOY has a forward P/E of 32.75. We also note that NHYDY has a PEG ratio of 0.26. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. NGLOY currently has a PEG ratio of 3.16.

Another notable valuation metric for NHYDY is its P/B ratio of 1.58. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, NGLOY has a P/B of 2.13.

Based on these metrics and many more, NHYDY holds a Value grade of A, while NGLOY has a Value grade of C.

NHYDY sticks out from NGLOY in both our Zacks Rank and Style Scores models, so value investors will likely feel that NHYDY is the better option right now.

Investors interested in stocks from the Automotive - Original Equipment sector have probably already heard of Autoliv, Inc. (ALV - Free Report) and Modine (MOD - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.

Currently, Autoliv, Inc. has a Zacks Rank of #2 (Buy), while Modine has a Zacks Rank of #3 (Hold). This means that ALV's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is just one piece of the puzzle for value investors.

Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.

Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.

ALV currently has a forward P/E ratio of 11.87, while MOD has a forward P/E of 31.02. We also note that ALV has a PEG ratio of 0.85. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. MOD currently has a PEG ratio of 0.91.

Another notable valuation metric for ALV is its P/B ratio of 3.77. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, MOD has a P/B of 7.13.

Based on these metrics and many more, ALV holds a Value grade of A, while MOD has a Value grade of C.

ALV sticks out from MOD in both our Zacks Rank and Style Scores models, so value investors will likely feel that ALV is the better option right now.

Key Takeaways MRNA/MRK evaluated intismeran autogene plus Keytruda in high-risk melanoma patients post-surgery.MRNA said intismeran autogene plus MRK's Keytruda cut recurrence or death risk by 49% after surgery.MRNA & MRK plan to share more follow-up data on primary/secondary endpoints at future medical conferences. Shares of Moderna (MRNA - Free Report) were up 15.8% on Jan. 21, after the company and its partner Merck (MRK - Free Report) announced positive median five-year follow-up data from a phase IIb study, which evaluated their personalized cancer therapy combo in certain patients with high-risk melanoma, a serious form of skin cancer.

The KEYNOTE-942/mRNA-4157-P201 study evaluated Moderna’s investigational mRNA-based individualized neoantigen therapy (INT), intismeran autogene (mRNA-4157 or V940), in combination with Merck’s blockbuster PD-L1 inhibitor, Keytruda (pembrolizumab), for treating patients with high-risk melanoma (stage III/IV) following complete resection.

Data from this pre-planned follow-up analysis showed that adjuvant treatment with intismeran autogene + Keytruda continued to demonstrate sustained and clinically meaningful improvement in recurrence-free survival — the primary endpoint of the study. The combo therapy reduced the risk of recurrence or death by 49% versus Keytruda alone in patients with high-risk melanoma following complete resection.

Per the company, patients suffering from stage III/IV melanoma remain at high risk of recurrence following surgery. The study demonstrating the long-term potential of intismeran autogene combined with Keytruda to lower the risk of recurrence in certain patients with melanoma marks an important milestone.

Moderna and Merck plan to share additional follow-up data on primary and secondary endpoints at an upcoming medical meeting.

This analysis from the phase IIb KEYNOTE-942/mRNA-4157-P201 study builds on the primary analysis conducted at around two years of follow-up and a subsequent analysis at three years of follow-up. The safety profile of intismeran autogene in combination with Keytruda in the study remains similar to that seen in previously reported studies.

MRNA’s Stock Price PerformanceMRNA stock hit a 52-week high following the announcement of the above news. In the past six months, shares of Moderna have rallied 60.8% compared with the industry’s rise of 21.5%.

Image Source: Zacks Investment Research

MRNA’s Ongoing Development Activities With Intismeran AutogeneIntismeran autogene is an experimental, personalized mRNA-based cancer therapy that is designed using the unique genetic mutations found in a patient’s tumor and can target up to 34 tumor-specific antigens.

Besides the melanoma indication, Moderna and Merck are evaluating the therapy in two pivotal phase III studies in the non-small cell lung cancer (NSCLC) space. Moderna and Merck are also evaluating the therapy across various mid-to-late-stage studies for other cancer indications, including melanoma, bladder cancer and renal cell carcinoma. A commercial launch for this cancer therapy is targeted for next year.

Based on the success achieved with intismeran autogene, Moderna is now focusing on expanding its oncology pipeline. It is also prioritizing the development of mRNA-4359, an investigational checkpoint adaptive immune modulation therapy, currently being evaluated in early-to-mid-stage studies for first-line melanoma and first-line metastatic NSCLC. A data readout on the phase II portion of this study is expected later in 2026.

MRNA’s Zacks Rank & Stocks to ConsiderModerna currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the biotech sector are Alkermes (ALKS - Free Report) and Immunocore (IMCR - Free Report) , both sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Over the past 60 days, estimates for Alkermes’ 2026 earnings per share (EPS) have increased from $1.54 to $1.90. Shares of ALKS have gained 27% over the past six months.

Alkermes’ earnings beat estimates in three of the trailing four quarters, while missing the same on the remaining occasion, with the average surprise being 4.58%.

Over the past 60 days, Immunocore’s loss per share estimates for 2026 have decreased from 97 cents to 90 cents. Shares of IMCR have lost 4.6% over the past six months.

Immunocore’s earnings beat estimates in three of the trailing four quarters, while missing the same on the remaining occasion, with the average surprise being 53.96%.

FormFactor (FORM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Item 1 of 3 Signage and logos for the Crypto firm BitGo during the company’s IPO outside the New York Stock Exchange (NYSE) in New York City, U.S., January 22, 2026. REUTERS/Brendan McDermid

[1/3]Signage and logos for the Crypto firm BitGo during the company’s IPO outside the New York Stock Exchange (NYSE) in New York City, U.S., January 22, 2026. REUTERS/Brendan McDermid Purchase Licensing Rights, opens new tab

Jan 22 (Reuters) - Crypto custody firm BitGo (BTGO.N), opens new tab was valued at ​about $2.59 billion after its shares ‌opened 24.6% higher in their New York Stock Exchange debut on Thursday.

The stock opened at $22.43 a share, compared with ‌the $18 offer price.

Sign up here.

BitGo and some of ​its backers sold 11.8 million shares above the marketed range of $15 and $17 ‍to raise $212.8 million.

The listing comes as the crypto IPO window tentatively reopens following tepid activity ⁠after the historic U.S. government ‍shutdown late last year. No major crypto-linked issuer went public ‌in ‌the U.S. in the fourth quarter.

Stablecoin issuer Circle (CRCL.N), opens new tab, CoinDesk-owner Bullish (BLSH.N), opens new tab, blockchain lender Figure (FIGR.O), opens new tab, and Winklevoss twins' crypto exchange Gemini (GEMI.O), opens new tab went ⁠public in ⁠New York ​between June to September.

The debut marks the first major test of investor appetite for ‍digital asset companies in 2026 and could influence whether other crypto firms move ahead ​with listing plans.

Reporting by ‍Atharva Singh and Arasu Kannagi Basil in Bengaluru; ​Editing by Tasim Zahid and Alan Barona

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Headquartered in Walla Walla, Banner (BANR - Free Report) is a Finance stock that has seen a price change of 5.38% so far this year. Currently paying a dividend of $0.50 per share, the company has a dividend yield of 3.03%. In comparison, the Financial - Savings and Loan industry's yield is 2.61%, while the S&P 500's yield is 1.37%.

Looking at dividend growth, the company's current annualized dividend of $2.00 is up 3.1% from last year. Over the last 5 years, Banner has increased its dividend 2 times on a year-over-year basis for an average annual increase of 4.50%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Banner's current payout ratio is 35%, meaning it paid out 35% of its trailing 12-month EPS as dividend.

BANR is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2026 is $5.89 per share, representing a year-over-year earnings growth rate of 3.33%.

From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. It's important to keep in mind that not all companies provide a quarterly payout.

Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, BANR is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.

Based in New Brunswick, Johnson & Johnson (JNJ - Free Report) is in the Medical sector, and so far this year, shares have seen a price change of 5.34%. The world's biggest maker of health care products is paying out a dividend of $1.30 per share at the moment, with a dividend yield of 2.39% compared to the Large Cap Pharmaceuticals industry's yield of 1.8% and the S&P 500's yield of 1.37%.

Looking at dividend growth, the company's current annualized dividend of $5.20 is up 1.2% from last year. Over the last 5 years, Johnson & Johnson has increased its dividend 5 times on a year-over-year basis for an average annual increase of 5.37%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Johnson & Johnson's current payout ratio is 50%, meaning it paid out 50% of its trailing 12-month EPS as dividend.

JNJ is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2026 is $11.46 per share, with earnings expected to increase 6.21% from the year ago period.

Investors like dividends for a variety of different reasons, from tax advantages and decreasing overall portfolio risk to considerably improving stock investing profits. It's important to keep in mind that not all companies provide a quarterly payout.

For instance, it's a rare occurrence when a tech start-up or big growth business offers its shareholders a dividend. It's more common to see larger companies with more established profits give out dividends. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, JNJ is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).